Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.

Wilson R, Cohen JM, Reglinski M, Jose RJ, Chan WY, Marshall H, de Vogel C, Gordon S, Goldblatt D, Petersen FC, Baxendale H, Brown JS.

PLoS Pathog. 2017 Jan 30;13(1):e1006137. doi: 10.1371/journal.ppat.1006137. eCollection 2017 Jan. Erratum in: PLoS Pathog. 2017 Mar 8;13(3):e1006259.

2.

Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.

Greene CJ, Marks LR, Hu JC, Reddinger R, Mandell L, Roche-Hakansson H, King-Lyons ND, Connell TD, Hakansson AP.

Infect Immun. 2016 May 24;84(6):1693-703. doi: 10.1128/IAI.01478-15. Print 2016 Jun.

3.

Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease.

Lagousi T, Routsias J, Piperi C, Tsakris A, Chrousos G, Theodoridou M, Spoulou V.

J Biol Chem. 2015 Nov 13;290(46):27500-10. doi: 10.1074/jbc.M115.666818. Epub 2015 Sep 22.

4.

DNA transducer-triggered signal switch for visual colorimetric bioanalysis.

Chen W, Yan Y, Zhang Y, Zhang X, Yin Y, Ding S.

Sci Rep. 2015 Jun 10;5:11190. doi: 10.1038/srep11190.

5.

Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.

Saxena S, Khan N, Dehinwal R, Kumar A, Sehgal D.

PLoS One. 2015 Feb 17;10(2):e0118154. doi: 10.1371/journal.pone.0118154. eCollection 2015.

6.

Development of Streptococcus pneumoniae Vaccines Using Live Vectors.

Wang S, Curtiss R 3rd.

Vaccines (Basel). 2014 Jan 7;2(1):49-88.

7.

Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.

Kaur R, Surendran N, Ochs M, Pichichero ME.

Infect Immun. 2014 Dec;82(12):5069-75. doi: 10.1128/IAI.02124-14. Epub 2014 Sep 22.

8.
9.

High Level Expression and Purification of Atl, the Major Autolytic Protein of Staphylococcus aureus.

Singh VK.

Int J Microbiol. 2014;2014:615965. doi: 10.1155/2014/615965. Epub 2014 Jan 19.

10.

Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.

Moffitt K, Skoberne M, Howard A, Gavrilescu LC, Gierahn T, Munzer S, Dixit B, Giannasca P, Flechtner JB, Malley R.

Infect Immun. 2014 May;82(5):2079-86. doi: 10.1128/IAI.01632-13. Epub 2014 Mar 10.

11.
12.

Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study.

Turner P, Turner C, Green N, Ashton L, Lwe E, Jankhot A, Day NP, White NJ, Nosten F, Goldblatt D.

Clin Microbiol Infect. 2013 Dec;19(12):E551-8. doi: 10.1111/1469-0691.12431.

13.

Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Berglund J, Vink P, Tavares Da Silva F, Lestrate P, Boutriau D.

Clin Vaccine Immunol. 2014 Jan;21(1):56-65. doi: 10.1128/CVI.00430-13. Epub 2013 Oct 30.

14.

Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear.

Schachern PA, Tsuprun V, Goetz S, Cureoglu S, Juhn SK, Briles DE, Paparella MM, Ferrieri P.

JAMA Otolaryngol Head Neck Surg. 2013 Sep;139(9):937-43. doi: 10.1001/jamaoto.2013.4104.

15.

Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Croney CM, Nahm MH, Juhn SK, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2013 Nov;20(11):1711-8. doi: 10.1128/CVI.00381-13. Epub 2013 Sep 4.

16.

Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.

Collins AM, Batrawy SE, Gordon SB, Ferreira DM.

Vaccine. 2013 Aug 2;31(35):3469-72. doi: 10.1016/j.vaccine.2013.04.062. Epub 2013 May 10.

17.

Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study.

Chen LF, Chen HP, Huang YS, Huang KY, Chou P, Lee CC.

PLoS One. 2012;7(12):e51452. doi: 10.1371/journal.pone.0051452. Epub 2012 Dec 12.

18.

Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West Africa.

Williams TM, Loman NJ, Ebruke C, Musher DM, Adegbola RA, Pallen MJ, Weinstock GM, Antonio M.

PLoS One. 2012;7(10):e26742. doi: 10.1371/journal.pone.0026742. Epub 2012 Oct 17.

19.

Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae.

Selva L, Ciruela P, Blanchette K, del Amo E, Pallares R, Orihuela CJ, Muñoz-Almagro C.

PLoS One. 2012;7(7):e41587. doi: 10.1371/journal.pone.0041587. Epub 2012 Jul 25.

20.

PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.

Croney CM, Coats MT, Nahm MH, Briles DE, Crain MJ.

Clin Vaccine Immunol. 2012 Jun;19(6):891-6. doi: 10.1128/CVI.05671-11. Epub 2012 Apr 25.

Supplemental Content

Support Center